243 related articles for article (PubMed ID: 11475077)
21. Number of metastatic sentinel nodes as predictor of axillary involvement in patients with breast cancer.
Zavagno G; De Salvo GL; Bozza F; Scalco G; Marconato R; Valletta S; Racano C; Burelli P; Nitti D; Lise M
Breast Cancer Res Treat; 2004 Jul; 86(2):171-9. PubMed ID: 15319569
[TBL] [Abstract][Full Text] [Related]
22. Additional tracer injection to improve the technical success rate of lymphoscintigraphy for sentinel node biopsy in breast cancer.
Heuts EM; van der Ent FW; van der Pol HA; von Meyenfeldt MF; Voogd AC
Ann Surg Oncol; 2009 May; 16(5):1156-63. PubMed ID: 19259741
[TBL] [Abstract][Full Text] [Related]
23. Sentinel node detection in cervical cancer with (99m)Tc-phytate.
Silva LB; Silva-Filho AL; Traiman P; Triginelli SA; de Lima CF; Siqueira CF; Barroso A; Rossi TM; Pedrosa MS; Miranda D; Melo JR
Gynecol Oncol; 2005 May; 97(2):588-95. PubMed ID: 15863164
[TBL] [Abstract][Full Text] [Related]
24. [Validation protocol of sentinel node biopsy for breast cancer using radioactive tracer at the Institute of Oncology Bucharest "Prof. Dr. Alexandru Trestioreanu"].
Blidaru A; Bordea C; Voinea S; Condrea I; Albert P; Houcheimi B
Chirurgia (Bucur); 2006; 101(4):391-9. PubMed ID: 17059150
[TBL] [Abstract][Full Text] [Related]
25. [Sentinel lymph node biopsy in breast cancer: the Lausanne experience].
Delaloye JF; Antonescu C; Besseghir N; Genton CY; Bischof-Delaloye A; De Grandi P
Rev Med Suisse Romande; 2000 Jun; 120(6):491-4. PubMed ID: 11014092
[TBL] [Abstract][Full Text] [Related]
26. 99mTc-Tetrofosmin pinhole-SPECT (P-SPECT) and radioguided sentinel node (SN) biopsy and in breast cancer axillary lymph node staging.
Spanu A; Dettori G; Chessa F; Porcu A; Cottu P; Solinas P; Falchi A; Solinas ME; Scanu AM; Nuvoli S; Madeddu G
Cancer Biother Radiopharm; 2001 Dec; 16(6):501-13. PubMed ID: 11789027
[TBL] [Abstract][Full Text] [Related]
27. Specification of potential indications and contraindications of sentinel lymph node biopsy in breast cancer.
Schlag PM; Bembenek A
Recent Results Cancer Res; 2000; 157():228-36. PubMed ID: 10857176
[TBL] [Abstract][Full Text] [Related]
28. Nonvisualization of axillary sentinel node during lymphoscintigraphy: is there a pathologic significance in breast cancer?
Brenot-Rossi I; Houvenaeghel G; Jacquemier J; Bardou VJ; Martino M; Hassan-Sebbag N; Pasquier J
J Nucl Med; 2003 Aug; 44(8):1232-7. PubMed ID: 12902412
[TBL] [Abstract][Full Text] [Related]
29. [Locating the sentinel node in breast cancer by gamma probe and staining agent. Preliminary study].
Vázquez Forner C; Giménez Climent J; Fliquete Peris MV; Fuster Diana C; Más Arcas C; Vázquez Albaladejo C
Rev Esp Med Nucl; 2000 Jun; 19(3):207-10. PubMed ID: 11062084
[TBL] [Abstract][Full Text] [Related]
30. Preoperative lymphoscintigraphy and internal mammary sentinel lymph node biopsy do not enhance the accuracy of lymphatic mapping for breast cancer.
Lawson LL; Sandler M; Martin W; Beauchamp RD; Kelley MC
Am Surg; 2004 Dec; 70(12):1050-5; discussion 1055-6. PubMed ID: 15663043
[TBL] [Abstract][Full Text] [Related]
31. Incidence of internal mammary node metastases after a sentinel lymph node technique in breast cancer and its implication in the radiotherapy plan.
Farrús B; Vidal-Sicart S; Velasco M; Zanón G; Fernández PL; Muñoz M; Santamaría G; Albanell J; Biete A
Int J Radiat Oncol Biol Phys; 2004 Nov; 60(3):715-21. PubMed ID: 15465187
[TBL] [Abstract][Full Text] [Related]
32. The prevalence of axillary lymph-node metastases in patients with pure tubular carcinoma of the breast and sentinel node biopsy.
Leikola J; Heikkilä P; von Smitten K; Leidenius M
Eur J Surg Oncol; 2006 Jun; 32(5):488-91. PubMed ID: 16569494
[TBL] [Abstract][Full Text] [Related]
33. Breast lymphoscintigraphy for sentinel node identification in breast cancers with clinically-negative axillary nodes.
Namwongprom S; Boonyaprapa S; Ekmahachai M; Vilasdechanon N; Somwangprasert A; Sumitsawan S; Taya P
Singapore Med J; 2005 Dec; 46(12):688-92. PubMed ID: 16308641
[TBL] [Abstract][Full Text] [Related]
34. The sentinel node in breast cancer--a multicenter validation study.
Krag D; Weaver D; Ashikaga T; Moffat F; Klimberg VS; Shriver C; Feldman S; Kusminsky R; Gadd M; Kuhn J; Harlow S; Beitsch P
N Engl J Med; 1998 Oct; 339(14):941-6. PubMed ID: 9753708
[TBL] [Abstract][Full Text] [Related]
35. The clinical value of parasternal sentinel node biopsy in breast cancer.
Leidenius MH; Krogerus LA; Toivonen TS; Leppänen EA; von Smitten KA
Ann Surg Oncol; 2006 Mar; 13(3):321-6. PubMed ID: 16485152
[TBL] [Abstract][Full Text] [Related]
36. Sentinel lymph node biopsy and axillary dissection in breast cancer: results in a large series.
Veronesi U; Paganelli G; Viale G; Galimberti V; Luini A; Zurrida S; Robertson C; Sacchini V; Veronesi P; Orvieto E; De Cicco C; Intra M; Tosi G; Scarpa D
J Natl Cancer Inst; 1999 Feb; 91(4):368-73. PubMed ID: 10050871
[TBL] [Abstract][Full Text] [Related]
37. Peritumoural versus subareolar administration of technetium-99m nanocolloid for sentinel lymph node detection in breast cancer: preliminary results of a prospective intra-individual comparative study.
Maza S; Valencia R; Geworski L; Zander A; Guski H; Winzer KJ; Munz DL
Eur J Nucl Med Mol Imaging; 2003 May; 30(5):651-6. PubMed ID: 12612811
[TBL] [Abstract][Full Text] [Related]
38. [Subareolar injection of 99m-Tc sulfur colloid for sentinel nodes identification in multifocal invasive breast cancer].
Mertz L; Mathelin C; Marin C; Gairard B; Chenard MP; Brettes JP; Bellocq JP; Constantinesco A
Bull Cancer; 1999 Nov; 86(11):939-45. PubMed ID: 10586110
[TBL] [Abstract][Full Text] [Related]
39. Technetium-99m-tetrofosmin in diagnosis of breast cancer and axillary lymph node involvement.
Jaukovic LDj; Ajdinovic BZ; Jankovic ZD; Strbac M
Nucl Med Rev Cent East Eur; 2006; 9(1):30-6. PubMed ID: 16791801
[TBL] [Abstract][Full Text] [Related]
40. Lymphoscintigraphic and intraoperative detection of the sentinel lymph node in breast cancer patients: the nuclear medicine perspective.
Mariani G; Erba P; Villa G; Gipponi M; Manca G; Boni G; Buffoni F; Castagnola F; Paganelli G; Strauss HW
J Surg Oncol; 2004 Mar; 85(3):112-22. PubMed ID: 14991882
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
